학술논문
A Phase 1/2 Study of Umbralisib Ublituximab and Venetoclax in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15280020